Copyright Reports & Markets. All rights reserved.

Global Pitavastatin Market Data Survey Report 2013-2025

Buy now

Table of Contents

    1 Global Market Overview

    • 1.1 Scope of Statistics
      • 1.1.1 Scope of Products
      • 1.1.2 Scope of Manufacturers
      • 1.1.3 Scope of Application
      • 1.1.4 Scope of Type
      • 1.1.5 Scope of Regions/Countries
    • 1.2 Global Market Size

    2 Regional Market

    • 2.1 Regional Production
    • 2.2 Regional Demand
    • 2.3 Regional Trade

    3 Key Manufacturers

    • 3.1 Kowa Pharmaceuticals
      • 3.1.1 Company Information
      • 3.1.2 Product & Services
      • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 3.2 CR Double-Crane Pharmaceuticals
      • 3.2.1 Company Information
      • 3.2.2 Product & Services
      • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

    4 Major Application

    • 4.1 Hypercholesterolaemia
      • 4.1.1 Overview
      • 4.1.2 Hypercholesterolaemia Market Size and Forecast
    • 4.2 Cardiovascular Disease
      • 4.2.1 Overview
      • 4.2.2 Cardiovascular Disease Market Size and Forecast
    • 4.3 Diabetes
      • 4.3.1 Overview
      • 4.3.2 Diabetes Market Size and Forecast
    • 4.4 Others
      • 4.4.1 Overview
      • 4.4.2 Others Market Size and Forecast

    5 Market by Type

      5.By 1 mg

      • 5.1 1 mg
        • 5.1.1 Overview
        • 5.1.2 1 mg Market Size and Forecast
      • 5.2 2 mg
        • 5.2.1 Overview
        • 5.2.2 2 mg Market Size and Forecast
      • 5.3 5 mg
        • 5.3.1 Overview
        • 5.3.2 5 mg Market Size and Forecast

      6 Price Overview

      • 6.1 Price by Manufacturers
      • 6.2 Price by Application
      • 6.3 Price by Type

      7 Conclusion

      Summary
      Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
      The global Pitavastatin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
      Global market size and forecast
      Regional market size, production data and export & import
      Key manufacturers profile, products & services, sales data of business
      Global market size by Major Application
      Global market size by Major Type
      Key manufacturers are included based on company profile, sales data and product specifications etc.:
      Kowa Pharmaceuticals
      CR Double-Crane Pharmaceuticals
      Major applications as follows:
      Hypercholesterolaemia
      Cardiovascular Disease
      Diabetes
      Others
      Major Type as follows:
      1 mg
      2 mg
      5 mg
      Regional market size, production data and export & import:
      Asia-Pacific
      North America
      Europe
      South America
      Middle East & Africa

      Buy now